Ultraschall Med 2022; 43(06): 599-607
DOI: 10.1055/a-1543-6033
Original Article

Contrast-Enhanced Ultrasound Improves the Accuracy of the ACR TI-RADS in the Diagnosis of Thyroid Nodules Located in the Isthmus

Kontrastverstärkter Ultraschall verbessert die Genauigkeit des ACR-TIRADS bei der Diagnose von Schilddrüsenknoten im Isthmus
Yunlin Huang
1   Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
,
Yurong Hong
1   Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
,
Wen Xu
1   Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
,
Kai Song
2   Department of Pathology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
,
Pintong Huang
1   Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
› Author Affiliations
Supported by: Natural Science Foundation of Zhejiang Province LGF19H180020
Supported by: National Natural Science Funds of China 81420108018
Supported by: Zhejiang Science and Technology Project 2019C03077
Supported by: The General Research Program of Education Bureau in Zhejiang Province Y201738146
Supported by: National Key R&D Program of China 2018YFC0115900

Abstract

Objectives To evaluate the diagnostic performance of the American College of Radiology (ACR) Thyroid Image Reporting and Data System (TI-RADS), contrast-enhanced ultrasound (CEUS), and a modified TI-RADS in differentiating benign and malignant nodules located in the isthmus.

Methods This retrospective study was approved by the institutional review board. Informed consent was obtained. Grayscale ultrasound (US) and CEUS images were obtained for 203 isthmic thyroid nodules (46 benign and 157 malignant) in 198 consecutive patients (156 women, mean age: 44.7 years ± 11.3 [standard deviation]; 47 men, mean age: 40.9 years ± 11.0). The area under the receiver operating characteristic curve (AUC) of the diagnostic performance of the ACR TI-RADS, CEUS, and the modified TI-RADS were evaluated.

Results Lobulated or irregular margins (P = 0.001; odds ratio [OR] = 9.250) and punctate echogenic foci (P = 0.007; OR = 4.718) on US and hypoenhancement (P < 0.001; OR = 20.888) on CEUS displayed a significant association with malignancy located in the isthmus. The most valuable method to distinguish benign nodules from malignant nodules was the modified TI-RADS (AUC: 0.863 with modified TR5), which was significantly better than the ACR TI-RADS (AUC: 0.738 with ACR TR5) (P < 0.001) but showed no significant difference with respect to CEUS (AUC: 0.835 with hypoenhancement) (P = 0.205). The diagnostic value was significantly different between CEUS and the ACR TI-RADS (P = 0.028).

Conclusion The modified TI-RADS could significantly improve the accuracy of the diagnosis of thyroid nodules located in the isthmus.

Zusammenfassung

Ziel Bewertung der diagnostischen Leistung des Thyroid Image Reporting and Data Systems (TIRADS) des American College of Radiology (ACR), des kontrastverstärkten Ultraschalls (CEUS) und eines modifizierten TIRADS zur Differenzierung von benignen und malignen Knoten im Isthmus.

Methoden Diese retrospektive Studie wurde durch die Ethikkommission (Institutional Review Board) genehmigt. Die Einverständniserklärungen wurden eingeholt. Graustufen-Ultraschall- (US) und CEUS-Bilder wurden für 203 isthmische Schilddrüsenknoten (46 benigne und 157 maligne) bei 198 konsekutiven Patienten (156 Frauen, Durchschnittsalter: 44,7 Jahre ± 11,3 (Standardabweichung); 47 Männer, Durchschnittsalter: 40,9 Jahre ± 11,0) gewonnen. Die Fläche unter der Receiver Operating Characteristic Curve (AUC) der diagnostischen Leistung von ACR-TIRADS, CEUS und modifiziertem TIRADS wurde bewertet.

Ergebnisse Lobulierte oder unregelmäßige Ränder (p = 0,001; Odds Ratio (OR) = 9,250) und punktförmige echogene Herde (p = 0,007; OR = 4,718) im US und Hypoenhancement (p < 0,001; OR = 20,888) im CEUS zeigten eine signifikante Assoziation mit Malignität im Isthmus. Die wertvollste Methode zur Unterscheidung von benignen und malignen Knoten war das modifizierte TIRADS (AUC: 0,863 mit modifiziertem TR5), welches signifikant besser war als ACR-TIRADS (AUC: 0,738 mit ACR TR5; p < 0,001), aber keinen signifikanten Unterschied zu CEUS (AUC: 0,835 mit Hypoenhancement) zeigte (p = 0,205). Der diagnostische Wert unterschied sich signifikant zwischen CEUS und ACR-TIRADS (p = 0,028).

Schlussfolgerung Das modifizierte TIRADS konnte die Genauigkeit der Diagnose von Schilddrüsenknoten im Isthmus signifikant verbessern.



Publication History

Received: 17 November 2020

Accepted: 18 June 2021

Article published online:
03 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Jasim S, Baranski TJ, Teefey SA. et al. Investigating the Effect of Thyroid Nodule Location on the Risk of Thyroid Cancer. Thyroid 2020; 30: 401-407
  • 2 Lee YS, Jeong JJ, Nam KH. et al. Papillary carcinoma located in the thyroid isthmus. World J Surg 2010; 34: 36-39
  • 3 Karatzas T, Charitoudis G, Vasileiadis D. et al. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: a case control study. Int J Surg Lond Engl 2015; 18: 64-68
  • 4 Iyer NG, Shaha AR. Management of thyroid nodules and surgery for differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 2010; 22: 405-412
  • 5 Wang J, Sun H, Gao L. et al. Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: a clinical study of 73 patients. Head Neck 2016; 38: 1510-1514
  • 6 Vasileiadis I, Boutzios G, Karalaki M. et al. Papillary Thyroid Carcinoma of the Isthmus: Total Thyroidectomy or Isthmusectomy?. Am J Surg 2018; 216: 135-139
  • 7 Polyzos SA, Kita M, Avramidis A. Thyroid nodules-stepwise diagnosis and management. Hormones (Athens) 2007; 6: 101-119
  • 8 Tessler FN, Middleton WD, Grant EG. et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14: 587-595
  • 9 Hahn SY, Han BK, Ko EY. et al. Ultrasound findings of papillary thyroid carcinoma originating in the isthmus: comparison with lobe-originating papillary thyroid carcinoma. Am J Roentgenol 2014; 203: 637-642
  • 10 Gao L, Xi X, Jiang Y. et al. Comparison among TIRADS (ACR TI-RADS and KWAK-TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules. Endocrine 2019; 64: 90-96
  • 11 Hoang JK, Middleton WD, Farjat AE. et al. Reduction in thyroid nodule biopsies and improved accuracy with American college of radiology thyroid imaging reporting and data system. Radiology 2018; 287: 185-193
  • 12 Basha MAA, Alnaggar AA, Refaat R. et al. The Validity and Reproducibility of the Thyroid Imaging Reporting and Data System (TI-RADS) in Categorization of Thyroid Nodules: Multicentre Prospective Study. Eur J Radiol 2019; 117: 184-192
  • 13 Zhang B, Jiang YX, Liu JB. et al. Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules. Thyroid 2010; 20: 51-57
  • 14 Trimboli P, Castellana M, Virili C. et al. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference. Radiol Med 2020; 125: 406-415
  • 15 Yu D, Han Y, Chen T. Contrast-enhanced ultrasound for differentiation of benign and malignant thyroid lesions: meta-analysis. Otolaryngol Head Neck Surg 2014; 151: 909-915
  • 16 Kwak JY, Han KH, Yoon JH. et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 2011; 260: 892-899
  • 17 Kim EK, Park CS, Chung WY. et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol 2002; 178: 687-691
  • 18 Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2009; 19: 1159-1165
  • 19 Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017; 27: 1341-1346
  • 20 Grani G, Lamartina L, Ramundo V. et al. Taller-Than-Wide Shape: A New Definition Improves the Specificity of TIRADS Systems. Eur Thyroid J 2020; 9: 85-91
  • 21 Kamaya A, Tahvildari AM, Patel BN. et al. Sonographic detection of extracapsular extension in papillary thyroid cancer. J Ultrasound Med 2015; 34: 2225-2230
  • 22 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
  • 23 Wildman-Tobriner B, Buda M, Hoang JK. et al. Using Artificial Intelligence to Revise ACR TI-RADS Risk Stratification of Thyroid Nodules Diagnostic Accuracy and Utility. Radiology 2019; 292: 112-119
  • 24 Lauria Pantano A, Maddaloni E, Briganti SI. et al. Differences between ATA, AACE ACE AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules. Eur J Endocrinol 2018; 178: 595-603
  • 25 Yuan Z, Quan J, Yunxiao Z. et al. Contrast enhanced ultrasound in the diagnosis of solitary thyroid nodules. J Can Res Ther 2015; 11: 41-45
  • 26 Zhang Y, Zhou P, Tian SM. et al. Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules. Eur Radiol 2017; 27: 1527-1536
  • 27 Li SY, Huang P, Cosgrove D. et al. Pseudoenhancement of Gallbladder Sludge: A Confusing Artifact Caused by Nonlinear Propagation of Ultrasound Through Microbubbles. Ultraschall in Med 2016; 37: 307-309
  • 28 Bönhof JA, McLaughlin G. Artifacts in Sonography – Part 3. Ultraschall in Med 2018; 39: 260-283
  • 29 Xu Y, Qi X, Zhao X. et al. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: one comparative cohort study. Medicine (Baltimore) 2019; 98: e14051